NEW: AbsoluteIDQ® p180 Kit: Now Available For Agilent Triple Quadrupole Mass Spectrometers
Innsbruck, Austria – June 3rd, 2019: BIOCRATES Life Sciences AG expands the applicability of its Targeted Profiling Kit technology to a new mass spectrometry platform.
As of June 2019, the AbsoluteIDQ® p180 Kit is available for 1290 Infinity II LC system - 6470 Agilent triple quadrupole mass spectrometer
Innsbruck, Austria – May 31, 2019: Biocrates Supports Restructuring of Metanomics Health GmbH
Press release (German/English)
March, 2019: Biocrates CEO Wulf Fischer-Knuppertz and Dr. Carmen Ludwig-Papst visit Professor Siqi Liu, one of the founders of BGI who is interested to develop the great opportunity for Biocrates technology in China.
BGI is operating the China National Gene Bank for the Chinese government and represents Biocrates in China for kit and service offerings.
AAIC Researchers Report New Data on How Gut Bacteria and Lipid Metabolism May Influence Alzheimer’s and Other Brain Diseases:
Innsbruck, Austria – July 25th, 2018 – BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer’s Disease Metabolomics Consortium’s (ADMC) new breakthrough in Alzheimer’s research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer’s disease (AD). During the Alzheimer’s Association International Conference (AAIC), Chicago, USA, researchers reported new data on how gut bacteria and lipid metabolism may influence AD.
Full press release:
Press release (English)
Press release (German)